INTRODUCTION
As the pioneering days of organ transplantation, organ cooling has been the means to keeping a graft sufficiently viable to transplant successfully. The organ is rapidly cold flushed with a cold preservation solution and stored on ice for the remainder of the ex-situ period. For livers the general consensus gives us a maximum of approximately 12-16 h [1] , whereas kidneys can be kept for longer and hearts for quite a bit shorter. This method of static cold storage allows transplantable organs to be kept viable for sufficiently long to accommodate the logistics of transplantation within an organ-sharing network. Although the success of static cold storage is commendable, the inevitable decay of the graft under these circumstances limits the time we have to transplant, distance that can be traveled, as well as the number of livers that are of sufficiently high quality to survive this additional ischemic injury. As the deficit in donor organs presses the transplant community to increase graft availability, we look to alternative preservation methods, including ex-situ machine preservation [2] and coveted subzero preservation techniques to improve organ availability. Although success in the latter has proven arduous, the importance of this field was emphasized in a recent Organ Banking summit [3] and recent innovations have renewed opportunities for the field to move forward. In this review, we discuss the field of subzero organ preservation with a focus on the liver. We describe the natural adaptations that lend lessons to this field, and review the various approached taken to achieve subzero organ preservation and the dawn of a new ice age.
Lessons from nature
Various observations from the natural world are of noteworthy relevance to subzero organ preservation. The finding that several species of frogs, including the wood frog Rana sylvatica, freeze solid during the cold winter was remarkable as both intra and extracellular freezing cause substantial lethality [4, 5] . Thorough investigation of these species with a natural tolerance to subzero external temperatures have indicated two adaptive approaches to subzero life; accommodating ice formation and ensuring it is limited to the extracellular space and preferably outside of the vital organs (freeze tolerance), and preventing freezing by taking advantage of freezing point depression and supercooling (freeze avoidance) [6] .
It was observed in Rana sylvatica that ice formation was selective, beginning in the extremities and if freezing persisted surrounding the abdominal organs in the peritoneal cavity. The entire process needed to be very carefully orchestrated to avoid crystallization or dehydration in vital parts of the body. Endogenous small-molecular cryoprotectants, including glucose and glycerol are produced to prevent cryoinjury and freezing in key body parts [7, 8] . This complex coordination of controlling ice formation, cryoprotectant distribution and order may be difficult to reproduce in solid organ preservation, as isolated organs have very little heterogeneity and sacrificial extracellular volume to allow a coordinated freezing scheme.
Freeze avoidance at subzero temperatures is a fundamentally different approach, employed by various insect and fish species [6, 9, 10] . Increased concentrations of cryoprotectants such as glucose and glycerol increase the molality in bodily fluids resulting in freezing-point depression in these species, similar to the manner that Rana sylvatica selectively protects vital body parts. Other species employ a high concentration of blood colloids, such as peptides [11] . These antifreeze peptides (AFP) exert a noncolligative antifreezing effect many times greater than what can be expected based on their molality, which results from a direct inhibition of ice crystal formation [12] . Five types of AFPs have been identified in fish and two types in insects ( Table 1 ) [13] .
In nature, freeze avoidance comes with certain risk, as the temperature cannot fall below the depressed freezing point. However, in controlled temperature settings, such as organ preservation, it may be highly applicable.
Subzero preservation of organs (as well as cells and tissues) shares many principles with coldtolerant species, making use of cryoprotectants, and controlled rates of freezing and rewarming to mitigate the effects of cryoinjury. Despite extensive research, attempts to achieve frozen organ preservation have been mostly unsuccessful. Both the mechanical injury from the formation of ice crystals as well as osmotic stress result in direct tissue damage and membrane injury during freezing and thawing [14] . In response, more successful alternatives have been explored where ice formation is avoided altogether. Vitrification, allows solutions to reach cryogenic temperatures without ice crystallization. Alternatively, organs can be kept in a supercooled condition below their freezing point. As long as ice nucleation can be prevented, solutions can also be maintained in a liquid state at subzero temperatures [15] , benefiting from a substantial reduction in metabolism.
Cryoprotectants
Freezing, vitrification, and supercooling all rely greatly on cryoprotectants to protect tissue from the formation of ice and cold-induced injury. Numerous low molecular weight additives have yielded promising results for cryoprotection, many of which are derived from natural freezetolerant and freeze-avoindant mechanisms. For some however, use is limited by toxicity of the molecule counteracting the benefit of the subzero temperature (ethylene glycol, dimethyl sulfoxide, 2,3-butanediol). Glycerol, sorbitol, 2,3-butanediol, 1,4-butanediol have been used to facilitate supercooling and mitigate cryopreservation injury [16] [17] [18] [19] . Various types of antifreeze proteins have been identified that modify ice structure into a less
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injurious configuration and prevent ice propagation by binding directly to crystals [20] . Moreover, these proteins were also found to have a direct protective effect by reducing membrane injury [21] .
ORGAN FREEZING
Freezing of whole organs is many times more complex than cryopreservation of single cell suspension [14] . In the latter, optimum freezing and thawing conditions can be determined to satisfy the requirements of the cell, whereas in whole organs a multitude of cell types are spatially arranged in a dense configuration involving not only cell junctions, but also matrix structure and cell-matrix interactions. Even minimal intracellular ice formation is destructive, but can often be avoided by controlled cooling and adequate use of cryoprotectants [22] . The work of Pegg et al. [14] elucidated the importance of the site of ice formation in the extracellular space. In various models, including smooth muscle tissue, cartilage, and in the more complex kidney, extracellular ice formation at less than 208C is directly damaging to the microstructure of tissue [23, 24] . In particular, the intravascular space in large solid organs is an important target of ice formation leading to vessel rupture [25] .
Attempts at frozen preservation of the liver have been sparse and generally with poor outcome. Early attempts followed very shortly after the first liver transplantation in 1963. Using 33% glycerol as a cryoprotectant, Moss et al. [18] froze canine livers at À208C ranging from 24 h to 2 weeks. Freezing resulted in substantial sinusoidal injury and matrix fragmentation, which resulted in a survival of only a few hours, severe coagulopathy and various metabolic disturbances when tranplanted heterotopically.
Only many years later was liver freezing attempted again by Rubinsky et al., closely mimicking the adaptive strategies of freeze-tolerant frogs and freeze-avoiding fish [26] . At a higher subzero temperature of À38C, rat livers were frozen by introducing ice crystals in a controlled fashion following infusion of 0.5 mol/l glycerol and 1 mg/ml AFP isolated from North Atlantic Cod, and kept for 6 h. On subsequent ex-vivo reperfusion livers produced bile, and had a well preserved histological morphology, compared with liver frozen in the absence of cryoprotectants. However, detached endothelium was observed and was likely the cause of high resistance during reperfusion. In a follow-up study, the group showed that endothelial cell detachment with good preservation of hepatocytes occurred as a result of freezing [27] . At this temperature, less than 60% of the water in the liver is frozen, preventing substantial injury to cells as a result of dehydration, which is supported by minimal hepatocyte damage. Interestingly, endothelial injury was absent in control experiments at the same temperature that were not frozen, but rather were preserved in a supercooled state, suggesting that it is freezing that damages the microvasculature directly, and not hypothermia [27] . On orthotopic transplantation, these livers produced bile, but survival was poor, which was attributed again to microvascular injury [28] . A single recipient survived 5 days and histology revealed an intact endothelium.
From limited studies in liver freezing it appears that deep-freezing results in an irreparable damage to various hepatic microstructures. A high subzero temperature limits ice formation and better preserves hepatocyte morphology and function, but remaining endothelial injury results in encumbering microvascular dysfunction.
VITRIFICATION
Not surprisingly, various groups came to the similar conclusion that preventing the formation of ice plays a central role in subzero preservation of organs. Organ vitrification gained interest starting around the year 2000, as a method to substantially cool down organs without the formation of ice crystals. Using various cryoprotectants that depress the freezing point and a rapid cooling scheme, the organs' temperature can be reduced to a glass transition temperature where the liquid assumes an amorphous, or glasslike state in which molecular movement effectively ceases [29] . To date, successful vitrification has been limited to small structures that can be easily cooled rapidly, like cell suspensions [30] , corneas, blood vessels [31] , reproductive tissue [32, 33] , and early developmental structures [34] [35] [36] . Liver vitrification remains limited to hepatocyte preservation and preservation of liver slices, used extensively for drug metabolism and toxicity studies, but remains unexplored in whole livers [37, 38] . Research into vitrification of other vascularized organs has primarily involved the kidney, in work from Fahy's group [29] . Even after achieving successful virtrification, a major challenge is preventing ice nucleation on rewarming, so called devitrification [39] . Using a 9.3 mol/l cryoprotectant solution known as M22, the group was able to prevent devitrification, restore renal function, and support life as the sole kidney after autotransplantation [40] . This isolated case remains the only report of successful vitrification of large solid organs, put is promising for the future of vitrification on optimization of vitrification solution and cooling-rewarming regimens.
SUPERCOOLING
The most successful results from subzero preservation come from supercooling techniques. The general consensus behind high subzero temperatures is that even a minor reduction in temperature can result in markedly improved liver preservation [41] . In-vitro hepatocyte storage is superior at subzero temperatures, with a better preservation of ATP levels and cell survival [42, 43] . In 1966 Brown et al. applied vacuum dehydration and 2 mol/l glycerol or dimethyl sulfoxide to permit nonfreezing of canine livers at À68C. Oxygen consumption ceased after 4-5 days of storage and survival of the 1-day stored grafts after heterotopic and orthotopic transplantation was less than 7 days and 12 h, respectively [44] . In an isolated liver perfusion model, it was shown that rat livers could be preserved unfrozen for 72 h at À48C, with similar outcome (bile production, aspartate transaminase/alanine transaminase release) to storage at þ48C in University of Wisconsin (UW) solution [45] . Toxicity of 2,3-butanediol, which was added to UW solution as a cryoprotectant may counteract the beneficial effect of supercooled temperature. In a similar study, Soltys et al. [16] also demonstrated that rat livers could be supercooled to À48C without freezing. Again 2,3-butanediol was used and was equally effective for 24 h preservation as 48C cold storage in UW solution. Addition of type 1 AFP did not improve hepatic function during isolated liver perfusion, but through an unclear mechanism did increased lactate dehydrogenase release. Importantly, adenine nucleotide content including ATP was significantly higher in supercooled livers. This finding was confirmed in a study by Yoshida et al. [46] who showed that ATP content and energy charge was better preserved in livers stored at À0.88C compared with those stored at 48C for up to 4 days. Although these results were promising, successful transplantation after long-term supercooled preservation is not reported, or even attempted.
In a recent study, our group demonstrated that rat livers could be successfully transplanted after 96 h of supercooling (À68C) preservation with long-term survival [47 && ]. Supercooling was combined with subnormothermic machine perfusion (SNMP; described here [48] ) for the loading of cryoprotectants into the liver as well as postsupercooling recovery. A nonmetabolizable glucose analogue (3-Omethyl glucose) was used as an intracellular cryoprotectant and 35 kDa polyethylene glycol was used to protect the extracellular compartment including the vasculature [49 & ]. Previous in-vitro work has demonstrated that 3-O-methyl glucose improved cryopreservation of primary hepatocytes, without evident toxicity [50] . With this protocol 100% survival after was achieved (3 month follow-up) after 72 h of supercooling, triple the 48C preservation time in UW solution [51] . After 96 h of storage, ATP content could be recovered to just under 50% of fresh values using SNMP -a level that corresponds to 48 h of cold storage in UW solution [52] . This correlation translates to transplant survival as well; after 96 h of supercooling survival was 58%, whereas survival is only 50% after just 2 days of cold storage [51] . Interestingly, survivors and nonsurvivors segregated over perfusion parameters during recovery SNMP; vascular resistance to perfusion flow as well as oxygen uptake may be useful in determining liver viability postsupercooling. It appears that even a minor supercooled state is able to significantly improve key aspects of preservation. Further experimentation with additional freezing point depressors and cryoprotectants may allow a further extension of preservation time as well as a more stable situation, better prepared for clinical translation. Figure 1 shows the setup of the presupercooling perfusion in the rat liver (Fig. 1) .
Alternative methods of achieving supercooled temperatures in the liver have been explored. Takahashi et al. [54] describes a short period of À28C supercooling by applying 10 MPa of pressure, which enabled 2-week survival after 5 h of preservation [53] ; however, slightly higher pressurization appeared to be damaging and some grafts were lost to freezing at even slightly lower temperatures. Monzen et al. [19] used a 100-500 V electrostatic field to achieve a temperature of À48C in livers, hearts, and kidneys preserved in UW solution, but postpreservation assessment was limited.
The importance of preserving the organ's energy status, and the use of ATP have been previously established [55,56 & ,57] . Slowing down metabolism and reducing high ATP consumption appears to be a key mechanism of cold storage and appears to be improved during supercooling. Preservation of organ energy status during supercooling has been confirmed in lungs [58] and hearts [59, 60] , where short-term supercooling preservation has been successfully performed, but transplantation has not been attempted.
Recent results in rat livers are encouraging, but successful scaling to larger-volume organs remains to be demonstrated. As ice nucleation is a stochastic process, a larger volume of water in human organs may be more challenging to keep unfrozen.
CLINICAL TRANSLATION AND CONCLUSION
The potential of organ banking remains widely acknowledged, but many challenges remain [3] . Both freezing and vitrification of the liver are hurdled by achieving ice-control and freeze-tolerance, whereas supercooling attempts freeze avoidance and appears to be the most promising approach for clinical translation in the short term, with successful preclinical results indicating feasibility of the technique. Vitrification has shown its potential for true long-term preservation in nonvascularized tissue and expansion to whole organs, such as the liver, would bring tremendous advance to the cryopreservation field.
Amidst a strong pursuit of novel warm preservation techniques, subzero preservation offers a relatively underexplored alternative. In our own work we have found supercooling to be an effective strategy to extend short-term preservation times significantly and efforts by others in the field of vitrification have made a tremendous push toward long-term storage of whole organs. It is our opinion that subzero preservation provides a relatively low complexity storage method for true organ banking to the extent of off-the-shelf organs preserved for extensive periods with minimal structural or metabolic deterioration.
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